Form 4 for THG HANOVER INSURANCE GROUP, INC.
Accepted 2026-05-21 16:26:17 ET · period of report 2026-05-19 · accession 0001428157-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-05-21 16:26 | 2026-05-19 | THG | Roche John C | Pres, CEO, Dir | M - OptEx | $99.10 | +33.1K | 174.1K | +23% | +$3.28M |
| DT | 2026-05-21 16:26 | 2026-05-19 | THG | Roche John C | Pres, CEO, Dir | F - Tax | $193.79 | -24.8K | 149.4K | -14% | -$4.80M |
| DMT | 2026-05-21 16:26 | 2026-05-20 | THG | Roche John C | Pres, CEO, Dir | S - Sale+OE | $193.74 | -8,358 | 141.0K | -6% | -$1.62M |
| DMT | 2026-05-21 16:26 | 2026-05-19 | THG | Roche John C | Pres, CEO, Dir | M - OptEx | $0.00 | -33.1K | 48.1K | -41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-19 | M | A | 9,098 | $85.87 | 150,108.75 | D | — | — | (F1) Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 24,766 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercises, resulting in a net issuance of 8,358 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. (F2) Does not include 14,454 shares held by the Reporting Person's spouse. |
| 2 | Common | Common Stock | 2026-05-19 | M | A | 24,026 | $104.11 | 174,134.75 | D | — | — | (F1) Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 24,766 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercises, resulting in a net issuance of 8,358 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. (F2) Does not include 14,454 shares held by the Reporting Person's spouse. |
| 3 | Common | Common Stock | 2026-05-19 | F | D | 24,766 | $193.79 | 149,368.75 | D | — | — | (F1) Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 24,766 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercises, resulting in a net issuance of 8,358 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. (F2) Does not include 14,454 shares held by the Reporting Person's spouse. |
| 4 | Common | Common Stock | 2026-05-20 | S | D | 3,152 | $193.21 | 146,216.75 | D | — | — | (F1) Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 24,766 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercises, resulting in a net issuance of 8,358 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. (F3) The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $192.70 to $193.69. The Reporting Person undertakes to provide The Hanover Insurance Group, Inc. ("THG"), any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F2) Does not include 14,454 shares held by the Reporting Person's spouse. |
| 5 | Common | Common Stock | 2026-05-20 | S | D | 5,145 | $194.05 | 141,071.75 | D | — | — | (F1) Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 24,766 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercises, resulting in a net issuance of 8,358 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. (F4) The price reported in Column 4 is a weighted average price. The shares were sold at multiple prices ranging from $193.73 to $194.72. The Reporting Person undertakes to provide THG, any security holder of THG, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F2) Does not include 14,454 shares held by the Reporting Person's spouse. |
| 6 | Common | Common Stock | 2026-05-20 | S | D | 61 | $194.77 | 141,010.75 | D | — | — | (F1) Pursuant to a pre-established Rule 10b5-1 Trading Plan, adopted on November 19, 2025, the Reporting Person's options were "net exercised". Accordingly, a total of 24,766 shares were withheld by the Company to satisfy the exercise price and taxes associated with the exercises, resulting in a net issuance of 8,358 shares, which were subsequently sold in accordance with the terms of the Rule 10b5-1 Trading Plan. (F2) Does not include 14,454 shares held by the Reporting Person's spouse. |
| 7 | Derivative | Common Stock Option (right to buy) | 2026-05-19 | M | D | 9,098 | $0.00 | 0 | D | $85.87 · — to 2027-02-24 | 9,098 Common Stock | (F5) The option, representing the right to purchase a total of 27,292 shares, vested 1/3 on each of 2/24/18, 2/24/19 and 2/24/20. |
| 8 | Derivative | Common Stock Option (right to buy) | 2026-05-19 | M | D | 24,026 | $0.00 | 48,052 | D | $104.11 · — to 2028-02-27 | 24,026 Common Stock | (F6) The option, representing the right to purchase a total of 72,078 shares, vested 1/3 on each of 2/27/19, 2/27/20 and 2/27/21. |